Literature DB >> 10785576

Quantitative characterization of eye tracking dysfunction in schizophrenia.

D L Levy1, C M Lajonchere, B Dorogusker, D Min, S Lee, A Tartaglini, J A Lieberman, N R Mendell.   

Abstract

The purpose of this study was to characterize the nature of the processes that are involved in eye tracking dysfunction (ETD). We identified a combination of quantitative measures that best distinguished qualitatively normal eye tracking from qualitatively abnormal eye tracking, using discriminant analysis. Discriminant scores distinguished schizophrenics with ETD from both schizophrenics with normal eye tracking and normal controls, but did not distinguish schizophrenics with normal eye tracking from normal controls, underscoring the heterogeneity of schizophrenic patients with respect to eye tracking. The results of the discriminant analysis indicated that ETD is a multivariate process involving a primary impairment in the smooth pursuit system characterized by increased catch-up saccades and reduced gain, and, secondarily, disinhibition of intrusive saccades, especially square-wave jerks. Quantitative characterization of ETD makes it possible to consider eye tracking as a quantitative trait in genetic investigations of a multidimensional phenotype.

Entities:  

Mesh:

Year:  2000        PMID: 10785576     DOI: 10.1016/s0920-9964(99)00122-x

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Eye movement and visual motion perception in schizophrenia I: Apparent motion evoked smooth pursuit eye movement reveals a hidden dysfunction in smooth pursuit eye movement in schizophrenia.

Authors:  W L Slaghuis; A Hawkes; T Holthouse; R Bruno
Journal:  Exp Brain Res       Date:  2007-06-19       Impact factor: 1.972

Review 2.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

Review 3.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.

Authors:  Deborah L Levy; Anne B Sereno; Diane C Gooding; Gilllian A O'Driscoll
Journal:  Curr Top Behav Neurosci       Date:  2010

4.  Response to unexpected target changes during sustained visual tracking in schizophrenic patients.

Authors:  L Elliot Hong; Matthew T Avila; Gunvant K Thaker
Journal:  Exp Brain Res       Date:  2005-05-10       Impact factor: 1.972

Review 5.  Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.

Authors:  Daniel C Javitt; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-11-17       Impact factor: 18.112

6.  Efference copy failure during smooth pursuit eye movements in schizophrenia.

Authors:  Miriam Spering; Elisa C Dias; Jamie L Sanchez; Alexander C Schütz; Daniel C Javitt
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

7.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

Review 8.  nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

Authors:  Vinay Parikh; Munir Gunes Kutlu; Thomas J Gould
Journal:  Schizophr Res       Date:  2016-01-21       Impact factor: 4.939

9.  Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia.

Authors:  Rebekka Lencer; Andreas Sprenger; Margret S H Harris; James L Reilly; Matcheri S Keshavan; John A Sweeney
Journal:  Arch Gen Psychiatry       Date:  2008-10

10.  Comparison of putative intermediate phenotypes in schizophrenia patients with and without obsessive-compulsive disorder: examining evidence for the schizo-obsessive subtype.

Authors:  Anna R Docherty; Michael J Coleman; Xiawei Tu; Curtis K Deutsch; Nancy R Mendell; Deborah L Levy
Journal:  Schizophr Res       Date:  2012-07-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.